We are live on ! Find out more
GI

GAMMA Investing Portfolio holdings

AUM $2.69B
1-Year Est. Return 42.78%
This Fund
S&P 500
This Quarter Est. Return
+4.14%
1 Year Est. Return
+42.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.99B
AUM Growth
+$177M
Cap. Flow
+$136M
Cap. Flow %
6.83%
Top 10 Hldgs %
28.11%
Holding
4,203
New
330
Increased
2,288
Reduced
1,042
Closed
109

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$10.4M
2
NVDA icon
NVIDIA
NVDA
+$6.62M
3
MSFT icon
Microsoft
MSFT
+$5.14M
4
EWC icon
iShares MSCI Canada ETF
EWC
+$4.46M
5
LLY icon
Eli Lilly
LLY
+$4.44M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$2.05M
2
GE icon
GE Aerospace
GE
+$1.19M
3
LIN icon
Linde
LIN
+$955K
4
K
Kellanova
K
+$804K
5
KMB icon
Kimberly-Clark
KMB
+$781K

Sector Composition

Rank Sector Weight
1 Technology 27.22%
2 Financials 12.87%
3 Consumer Discretionary 9.03%
4 Healthcare 8.77%
5 Industrials 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGC icon
3351
Superior Group of Companies
SGC
$225M
$978 ﹤0.01%
101
-203
-67% -$1.98K
TRDA icon
3352
Entrada Therapeutics
TRDA
$267M
$977 ﹤0.01%
95
+66
+228% +$556
XBI icon
3353
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$975 ﹤0.01%
8
XSD icon
3354
State Street SPDR S&P Semiconductor ETF
XSD
$2.93B
$965 ﹤0.01%
3
DAWN
3355
DELISTED
Day One Biopharmaceuticals
DAWN
$960 ﹤0.01%
103
+64
+164% +$535
TTGT icon
3356
TechTarget
TTGT
$278M
$956 ﹤0.01%
177
-1,153
-87% -$6.21K
ACGLN icon
3357
Arch Capital Group Series G Preferred Stock
ACGLN
$952 ﹤0.01%
+57
New +$992
IMO icon
3358
Imperial Oil
IMO
$60.4B
$949 ﹤0.01%
11
LAB icon
3359
Standard BioTools
LAB
$314M
$941 ﹤0.01%
+735
New +$987
STIM icon
3360
Neuronetics
STIM
$166M
$940 ﹤0.01%
+681
New +$1.43K
FSP
3361
Franklin Street Properties
FSP
$46.8M
$939 ﹤0.01%
993
-11,665
-92% -$13.6K
LEGH icon
3362
Legacy Housing
LEGH
$694M
$937 ﹤0.01%
48
+33
+220% +$707
TBBB icon
3363
BBB Foods
TBBB
$4.92B
$935 ﹤0.01%
28
HBB icon
3364
Hamilton Beach Brands
HBB
$422M
$921 ﹤0.01%
+56
New +$849
MLP icon
3365
Maui Land & Pineapple Co
MLP
$344M
$915 ﹤0.01%
54
MNPR icon
3366
Monopar Therapeutics
MNPR
$799M
$914 ﹤0.01%
14
+3
+27% +$245
VTS icon
3367
Vitesse Energy
VTS
$665M
$905 ﹤0.01%
47
-228
-83% -$4.87K
VIA
3368
Via Transportation Inc
VIA
$1.81B
$899 ﹤0.01%
+31
New +$1.28K
CRCT icon
3369
Cricut
CRCT
$1.22B
$891 ﹤0.01%
180
-471
-72% -$2.4K
NC icon
3370
NACCO Industries
NC
$320M
$883 ﹤0.01%
18
-29
-62% -$1.33K
CFBK icon
3371
CF Bankshares
CFBK
$236M
$873 ﹤0.01%
+35
New +$836
FENC icon
3372
Fennec Pharmaceuticals
FENC
$402M
$870 ﹤0.01%
113
UA icon
3373
Under Armour Class C
UA
$2.53B
$869 ﹤0.01%
181
-6,400
-97% -$28.5K
VTEX icon
3374
VTEX
VTEX
$713M
$865 ﹤0.01%
+230
New +$943
FSFG
3375
DELISTED
First Savings Financial Group
FSFG
$860 ﹤0.01%
+27
New +$839

Similar funds

GAMMA Investing's Q4 2025 Portfolio in Review

As of Q4 2025, GAMMA Investing held 4,203 positions worth $1.99B, up 9.8% from $1.81B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

GAMMA Investing deployed $136M of net new capital in Q4 2025, opening 330 new positions and adding to 2,288 existing holdings. Its largest new stake was iShares MSCI Canada ETF: 86,202 shares worth $4.65M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was JPMorgan Chase, an estimated $2.05M trimmed.

  • GAMMA Investing's largest Q4 2025 buy was iShares MSCI Canada ETF: 86,202 shares worth $4.65M.
  • GAMMA Investing added most to Apple in Q4 2025, an estimated $10.4M increase.
  • GAMMA Investing's biggest Q4 2025 reduction was JPMorgan Chase, cutting an estimated $2.05M.
  • GAMMA Investing fully exited Kellanova in Q4 2025, selling an estimated $804K.
  • GAMMA Investing's ten largest holdings make up 28% of its $1.99B portfolio in Q4 2025.
  • GAMMA Investing opened 330 new positions and closed 109 in Q4 2025.
  • GAMMA Investing's portfolio value rose 9.8% quarter-over-quarter to $1.99B.

Based on GAMMA Investing's 13F filing for Q4 2025, filed 5 Jan 2026.